[ad_1]
Source: Reuters
The results of a small trial in Hong Kong indicated that a combination of three antivirals helped alleviate symptoms in people with mild to moderate cases of Covid-19 caused by the Coronavirus, and quickly reduced the amount of virus in their bodies.
This trial, which included 12 patients, compared those who received the combination drug lupinavir / ritonavir to treat HIV, the drug ribavirin to treat hepatitis C, the drug interferon beta to treat multiple sclerosis and a given control group. . HIV only.
The results were published in the journal “Lancet Medical” and showed that people who received the combined drug reached the point of not detecting the virus in their bodies five days earlier than the participants in the control group, that is, seven days versus 12 days.
“Our experience shows that initial treatment for Covid-19 cases, which ranged from mild to moderate, with antivirals, can accelerate virus suppression in the patient’s body, alleviate symptoms and reduce risk for workers.” said Cook Yung Yuen, a professor at the University of Hong Kong who co-chaired the research. In health care. “
He added that the reduced risk for health workers is due to the effect of this triple combination on the “viral test” that occurs when the virus can be discovered and the possibility of transmission.
[ad_2]
